Intimation under Regulation 8(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015, Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information ....
GAUDIUMIVF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gaudium IVF and Women Health Ltd has formally submitted its Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (UPSI) to BSE and NSE, as required under Regulation 8(2) of SEBI's Insider Trading Regulations, 2015. The code, originally approved by the Board of Directors on November 4, 2024, outlines how the company will handle confidential information that could impact its stock price. It covers definitions of UPSI, rules for sharing sensitive information with insiders on a need-to-know basis, criteria for legitimate purposes, and procedures for maintaining a structured digital database of UPSI sharing. The filing also includes a policy on what counts as a 'legitimate purpose' for sharing UPSI and protocols for handling any suspected leakage of sensitive information.
This is a routine regulatory compliance filing with no material impact on the company's financials, operations, or stock price. It simply formalizes the company's existing insider trading and disclosure policies as required by SEBI rules, offering shareholders reassurance that the company has structured safeguards against insider trading violations.